Global Leading Companies & Different Growth Strategies Adopted by Them:
The global pharmaceutical drug delivery market is highly competitive, with many leading market players based in developed countries.
The prominent players in this market are Johnson & Johnson (US), Novartis International AG (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Pfizer Inc. (US), Bayer AG (Germany), Antares Pharma, Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), 3M (US), Merck & Co., Inc. (US), Sanofi (France), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim (Germany), AstraZeneca plc. (UK), Eli Lilly and Company (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol-Myers Squibb (US), Gerresheimer AG (Germany), Boston Scientific Corporation (US), Nimbus Therapeutics (US), Kite Pharma (US), and IDEAYA Biosciences, Inc. (US).
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
However, several smaller players have emerged from niche markets in the past few years, competing with global players based on price and product offerings. Due to intense competition in the market, major market players are increasingly focusing on expanding their geographic presence into high-growth emerging markets and strengthening their technological competitiveness by acquiring smaller players with the desired technological capabilities or geographical presence.
Overview of This Research:
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Market Size Estimation:
The total size of the pharmaceutical drug delivery market was arrived at after data triangulation from different approaches, as mentioned below. After each approach, the weighted average of the approaches was taken based on the level of assumptions used in each approach.
Expected Revenue Growth:
The global pharmaceutical drug delivery market is projected to reach USD 2,206.5 billion by 2026 from USD 1,656.9 billion in 2021, at a CAGR of 5.9% during the forecast period.
Data Triangulation:
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
The leading position of Johnson & Johnson (J&J) (US) in this market is due to its strong brand recognition. The company focuses on adopting organic as well as inorganic growth strategies to expand its presence in the drug delivery technology market. For instance, in April 2020, Janssen Pharmaceutical Companies collaborated with Emergent BioSolutions to support the manufacturing and expansion of its investigational COVID-19 vaccine. Janssen aims to supply over a billion doses of their vaccine worldwide. In January 2019, Janssen (J&J) collaborated with MeiraGTx Holdings (US) to develop, manufacture, and commercialize its clinical-stage inherited retinal disease drug portfolio.
F. Hoffmann-La Roche Ltd. (Switzerland) was the third-largest player in the pharmaceutical drug delivery market. In order to strengthen its position in the pharmaceutical drug delivery market, the company focuses on receiving approvals for various therapeutic applications. Some of its recent product approvals include Tecentriq (atezolizumab) for the treatment of Liver Cancer, metastatic non-squamous non-small cell lung cancer (NSCLC); Venclexta (venetoclax) for the treatment of people with newly-diagnosed acute myeloid leukemia (AML), Chronic lymphocytic leukemia; Polivy for Lymphoma, and Xofluza (baloxavir marboxil) for the treatment of flu (influenza).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Asia Pacific is expected to account for the highest CAGR for players operating in the pharmaceutical drug delivery market
During the forecast period, the Asia Pacific is expected to be the fastest-growing regional market for pharmaceutical drug delivery. The rapid rise in the geriatric population, increased prevalence of chronic diseases, increased healthcare expenditure, increased R&D activities conducted in this region, growth in technological collaborations for pharmaceutical drug delivery technologies, favorable reimbursement policies, and growth in disposable incomes in the emerging Asian economies, such as China and India, are factors that are expected to drive the growth of the APAC market during the forecast period.
